14:00

Introduction and Welcome

  • Andrew Smith, Group Leader, Smith Lab, UCL
  • James Lee, Group Leader, Genetic Mechanisms of Disease Laboratory, The Francis Crick Institute
  • Gautam Mehta, Associate Professor, Institute for Liver & Digestive Health, UCL
  • Greg Sebepos-Rogers, Trainee, UCH, UCLH
14:30

Keynote Speaker Presentation

  • James Lee, Group Leader, Genetic Mechanisms of Disease Laboratory, The Francis Crick Institute
15:00

Coffee break

Industry stands and refreshments

Lightning Talks

15:20

The impact of IL-2RA polymorphism on immune cell phenotype and function in Crohn’s disease

  • Jennie Clough, PhD student, LORD Lab, King’s College London
15:30

Mesenteric fibrosis in small intestinal neuroendocrine tumours (SI-NETs): pathogenesis and therapeutic targets

  • Maria Martins, PhD student, Rombouts Lab, Regenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, University College London
15:40

The utility of colonic organoids in modelling immune checkpoint inhibitor induced colitis

  • Dr Hajir Ibraheim, PhD student, Powell Lab, Imperial College London
15:50

Toll-like receptor 5 signalling mediates pro-inflammatory and fibrogenic responses in metabolic dysfunction-associated steatohepatitis (MASH)

  • Dr Wenhao Li, Academic Clinical Lecturer, Alazawi Lab, Blizard Institute, Queen Mary University of London
16:00

Linking Genetic Susceptibility to Environmental Risk – The Role of the Aryl Hydrocarbon Receptor in IBD

  • Anna Kunkel, Research student, Lee and Stockinger Labs, Francis Crick Institute
16:10

Patient and Public Involvement and Engagement

  • Rachel Ainley, Head of Research & Evidence, Crohn’s & Colitis UK
  • Vanessa Hebditch, British Liver Trust
16:30

Networking & Refreshments

18:30

Meeting close